Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Ab - International Health Care Portfolio C Acc (LP65068120)
Add to/Remove from a Portfolio
Add to Watchlist
436.360
-1.110
-0.25%
- Morningstar Rating:
- Total Assets: 3.96B
AB SICAV I - International Health Care Portfolio C
436.360
-1.110
-0.25%
- General
- Chart
- News & Analysis
- Forum
- Overview
- Profile
- Historical Data
- Holdings
LP65068120 Overview
On this page you'll find an in-depth profile of Ab - International Health Care Portfolio C Acc. Learn about the key management, total assets, investment strategy and contact information of LP65068120 among other information.
Contact Information
Address
One International Finance Centre
Hong Kong, L-2453
Hong Kong
Hong Kong, L-2453
Hong Kong
Phone
+352 46 39 36 151
Web
www.abglobal.com
Top Executives
| Name | Title | Since | Until |
|---|---|---|---|
| John H. Fogarty | Senior Vice President | 2019 | Now |
| Biography | John Fogarty is a Senior Vice President and Portfolio Manager for U.S. Growth Equities at AB, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the U.S., having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Varden Partners. Mr. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Mr. Fogarty holds a B.A. in history from Columbia University and is a CFA charterholder. | ||
| Vinay Thapar | Senior Vice President | 2013 | Now |
| Biography | Vinay Thapar is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities and a Portfolio Manager for the Global Healthcare Strategy. He is also a Senior Research Analyst, responsible for covering global healthcare. Before joining the firm in 2011, Thapar spent three years at American Century Investments as a senior investment analyst responsible for healthcare. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York | ||
| John H. Fogarty | Senior Vice President | 2013 | 2018 |
| Biography | John Fogarty is a Senior Vice President and Portfolio Manager for U.S. Growth Equities at AB, a position he has held since 2009. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the U.S., having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Varden Partners. Mr. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Mr. Fogarty holds a B.A. in history from Columbia University and is a CFA charterholder. | ||
| Bryce Hill | - | 2013 | 2015 |
| Biography | Mr. Hill is portfolio manager for the Disciplined Value strategy. He heads the global Health Care sector team and is a senior research analyst for the firm’s value/core equity strategies focusing on the health care and technology sectors. Mr. Hill is a CFA charterholder and holds an MBA from Columbia University and a BS in Business Administration, summa cum laude, from the University of Southern California. | ||
| Tassos M. Stassopoulos | Senior Vice President | 2011 | 2013 |
| Biography | Tassos founded Trinetra in 2016 as a small, dedicated investment boutique using ethnographic research to capture growth opportunities in emerging markets. Tassos believes that understanding consumer’s mindsets in their cultural context allows investors to anticipate trends, which not only improves investment outcomes, but also helps people in Emerging Markets to realise their dreams. Prior to that, Tassos was Head of EM Growth Equity at Ashmore which he joined after nine years at AllianceBernstein where he was Portfolio Manager for Emerging Consumer, Global Growth and Thematic equity products. He was previously a Managing Director at Credit Suisse and for six years he was the senior analyst for European travel and leisure, twice ranked number 1 in the Institutional Investor survey. He then spent a year as a Portfolio Manager at the firm’s internal hedge fund, Modal Capital. He also spent eight years as a Chartered Accountant and then as a management consultant at Arthur Andersen. Tassos holds an MA in Economics from Cambridge University and is a Fellow of the Institute of Chartered Accountants. | ||
| Steven Nussbaum | - | 2007 | 2012 |
| Biography | Dr. Nussbaum manages the AllianceBernstein Healthcare Funds and is also the Healthcare Sector Head for Global Research Growth. Prior to joining Alliance Capital in 2002, Dr. Nussbaum worked as a Medical Products analyst at JP Morgan from 1999-2002. Prior to coming to Wall Street, he was an attending physician and a Clinical Assistant Professor of Radiology at Thomas Jefferson University Hospital in Philadelphia and before that he was an attending physician at Long Island Jewish Medical Center in New York. Dr. Nussbaum completed a radiology fellowship at Thomas Jefferson University Hospital, a radiology residency at Montefiore Medical Center in New York, and a medical internship at Danbury Hospital in Connecticut. He holds a BA from Harvard University, an MD from the Albert Einstein College of Medicine, and an MBA from the NYU Stern School of Business. | ||
| Norman M. Fidel | Senior Vice President | 1995 | 2007 |
| Biography | Fidel is a senior vice president of AllianceBernstein. He joined the firm from Eberstadt Asset Management, where he served as a senior vice president and the director of research. Prior to that, he was a security analyst with Irving Trust Company. Fidel is a member of the New York Society of Security Analysts and the Health Industries Analyst Group of New York. | ||
Write your thoughts about Ab - International Health Care Portfolio C Acc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review